Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
CardiaBeat Now NDI
July 24, 2006
1 Min Read
MIGDAL HAEMEQ, Israel—Enzymotec announced the U.S. Food and Drug Administration (FDA) approved the company’s petition for New Dietary Ingredient (NDI) status for its CardiaBeat™ dietary ingredient. The product is designed to deliver plant sterols plus long-chain omega-3 essential fatty acids (EFAs), including docosahexaenoic acid (DHA) and eicosapenaenoic acid (EPA), to improve various cardiovascular disease risk factors. Enzymotec (www.enzymotec.com) develops and manufactures bio-functional ingredients for dietary supplements, functional foods and infant formulas.
You May Also Like